Poliomyelitis primarily affects infants and children but can be contracted at any age. Paralysis and mortality are most common in the first 5 years of life, underscoring the importance of early immunization. Biopolio (live attenuated poliomyelitis type 1 and type 3 viruses—Sabin strain) is used to actively immunize infants and children against Poliomyelitis.
BioPolio B1/3 is a WHO Prequalified oral polio vaccine by Bharat Biotech.
Your email address will not be published. Required fields are marked *